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ABSTRACT 
  Since the discovery of the polymerase chain reaction (PCR) 20 years ago an avalanche of 
scientific publications have reported major developments and changes in specialized equipment, 
reagents, sample preparation, computer programs, and techniques generated through business, 
government and university research.  The requirement for genetic sequences for primer selection and 
validation has been greatly facilitated by development of new sequencing techniques, machines, and 
computer programs.  Genetic libraries, such as, GenBank, EMBL, or DDBJ continue to accumulate a 
wealth of genetic sequence information for development and validation of molecular-based diagnostic 
procedures concerning human and veterinary disease agents.  Mechanization of various aspects of 
the PCR assay, such as, robotics, microfluidics, and nanotechnology has made it possible for rapid 
advancement of new procedures.  Real-Time PCR, DNA microarray, and DNA chips utilize these 
newer techniques in conjunction with computer and computer programs.  Instruments for hand-held 
PCR assays are being developed.  The PCR and RT-PCR assays have greatly accelerated the speed 
and accuracy of diagnoses of human and animal disease, especially of the infectious agents that are 
difficult to isolate or demonstrate.  The PCR has made it possible to genetically characterize a 
microbial isolate inexpensively and rapidly for identification, typing, and epidemiological comparison. 
 
TEXT 
The polymerase chain reaction (PCR) was discovered by Mullis in 1983
 (Mullis et al, 1986, 
1987) and he received a Nobel Prize for this achievement a decade later.  Awareness of the 
significance of the PCR technique had spread throughout the scientific community of the world by the 
end of the 1980’s and scientific articles were being published concerning the various uses of the PCR 
technique.  By 1990 there was a considerable pool of 16S RNA gene sequences, which had been 
generated for phylogeny of microorganisms and these sequences could be used for primer selection 
by sequence alignment.  New sequencing techniques, sequencing machines and computer programs 
for manipulation of sequence information have been developed that have greatly accelerated the 
accumulation of genetic sequences for development of newer and better PCR assays.  The use of the 
Internet has made it possible to access scientific information for comparison of genetic sequences 
from around the world.  Genetic libraries (GenBank, EMBL, DDBJ) continue to accumulate a broad 
selection of genetic sequence information for development and validation of molecular-based 
diagnostic procedures concerning human and veterinary disease agents. 
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The initial thermal cycler used in our laboratory in 1990 was a Perkin-Elmer model 480, which 
had a refrigeration unit to speed the rate of cooling and did not have the heated lid technology.   
Nanotechnology was utilized from the beginning of these techniques.  Simple computer hardware and 
software were built into the early thermal cyclers.  The next generation of thermal cyclers had heated 
lids, no refrigeration (worked off ambient temperature using fans), and more memory for programs.  
With the development of Real-Time PCR the instruments became more elaborate and expensive.  The 
use of standard computers and specialized computer software were necessary to run the Real-Time 
PCR assays.  The Real-Time PCR technology requires new primers and fluorescent tagged probes to 
be developed that are much more expensive to prepare.  The major advantage of Real-Time PCR 
over standard PCR assay is the one tube and one time handling with the reading of the reaction 
during the assay. 
 
Initially the simple procedure of boiling was used to release DNA from the sample and to obtain 
a greater yield the phenol-chloroform technique was used.  Less toxic chemicals were researched for 
release and harvest of the nucleic acids.  Then DNA and RNA affinity materials were used for 
extraction of the nucleic acids.  Initially the microcentrifuge and chemical hoods were the instruments 
necessary for DNA/RNA extraction with a lot of hands on effort.  Instruments have been developed 
using microfluidics, nanotechnology and robotics to process the samples automatically.  Automatic 
sample collection is being developed using remote access air-samplers to evaluate environments for 
high-risk pathogens of public health importance or routine sampling of animal environments, such as, 
poultry houses, swine barns, milking parlors, or food processing plants for specific pathogens of 
economic or public health importance. 
 
One of the most important developments for the PCR technology was the discovery and use of 
the Taq DNA polymerase enzyme.  By 1990, standard reagents (PCR buffer, dNTP, MgCl2, and Taq 
DNA polymerase) were commercially available for PCR assays.  One of the limiting factors at the time 
was the relatively small amount of sequence information for specific organisms.  In 1990, we were 
attempting to develop species-specific primers for Mycoplasma synoviae and sequenced a portion of a 
DNA probe used in Israel to detect the organism.  Specific primers were not developed using this 
approach.  However, in 1991, the last half of the 16S rRNA gene sequence of M. synoviae was 
entered into the GenBank by an Australian team of scientists.  A complete sequence of Mycoplasma 
gallisepticum 16 S rRNA gene sequence was found to perform a sequence alignment, which allowed 
us to select a set of species-specific primers for M. synoviae.  The BLAST program 
(http://www.ncbi.nlm.nih.gov/BLAST/) came available and this was of great assistance in rapid 
computer evaluation of primer sequences for specificity by testing them against all sequences on the 
GenBank.  As the years passed, sequence information concerning a greater number of organisms  
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were submitted to the various genetic libraries and thus we were able to develop a variety of primers 
and publish a PCR manual entitled “Nucleic acid amplification assays for diagnosis of animal 
diseases” (Lauerman, 1998).  Recently PCR assays have been used to evaluate vaccines for the 
presence or absence of specific disease agents (Lauerman, 2002). 
 
Improvements in buffers have given greater stability and longer activity for reagents and 
enzymes, which has contributed to improved PCR and RT-PCR techniques.  Since the discovery of 
Taq DNA polymerase, many improvements have been made, such as, synthesis of a recombinant 
polymerase omitting undesirable side effects.  Other polymerase enzymes have been isolated and 
evaluated from a number of thermophilic organisms having a variety of activities different from Taq 
DNA polymerase allowing for longer segments of DNA to be produced as PCR amplicon with greater 
accuracy. 
 
New technology has been developed, such as, DNA microarray and DNA chips, that give 
hundreds to thousands more genetic information in a shorter period of time than the original PCR 
techniques.  A detailed description of the DNA microarray procedure can be found on the following 
web sites http://www.vetscite.org/cgi-bin/pw.exe/issue3/000035/000035.htm or http://www.gene-
chips.com/.  The DNA microarray  technology will also be described in detail in the next paper 
presentation at this conference. 
 
The PCR technology has made it possible to genetically characterize microbial isolates 
inexpensively and rapidly for identification, typing, and epidemiological evaluation.  The emphasis on 
Homeland Security and Bioterrorism Preparedness has expanded the need for more rapid and highly 
accurate diagnostic capabilities to protect the public health, animal agriculture and associated 
industries in the United States and the world. 
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